Balyasny Asset Management
SHAC

Balyasny Asset Management’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Balyasny Asset Management’s Portfolio SHAC Stock Details SHAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,732,500
Closed -$17.1M – 3493
2022
Q3 		$17.1M Hold
1,732,500
– – 0.05% 480
2022
Q2 		$17M Hold
1,732,500
– – 0.06% 478
2022
Q1 		$17M Hold
1,732,500
– – 0.05% 486
2021
Q4 		$17M Hold
1,732,500
– – 0.06% 477
2021
Q3 		$16.9M Hold
1,732,500
– – 0.07% 389
2021
Q2 		$16.7M Hold
1,732,500
– – 0.08% 340
2021
Q1 		$16.6M Buy
+1,732,500
New +$16.8M 0.08% 323

Balyasny Asset Management's SHAC Position: Q4 2022 in Review

Balyasny Asset Management sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,732,500 shares — an estimated $17.1M sold.

Balyasny Asset Management first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $17.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

  • Balyasny Asset Management reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,732,500 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $17.1M.
  • Balyasny Asset Management first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Balyasny Asset Management's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $17.1M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.